[Treatment of psoriasis with an orally administered effective new vitamin A acid derivative. Preliminary report].
The retinoic acid derivative Ro 10-9359 has been tested in 24 patients with psoriasis. In all patients the therapeutic activity was good to excellent. The symptoms of the hypervitaminosis A syndrome were slight to marked. The ratio between the therapeutic effectiveness and the side effects was favourable only in cases with severe psoriasis.